Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
8 results
Topics : Diseases and conditions
Language : Français
Active substance : infliximab
OK
Chercher
Filter
Topic
Diseases and conditions
(8)
Plus ...
Immune system diseases
(7)
Plus ...
Autoimmune diseases
(7)
Musculoskeletal diseases
(7)
Plus ...
Joint and rheumatic diseases
(7)
Digestive system diseases
(4)
Plus ...
Esophageal and gastrointestinal diseases
(4)
Digestive system diseases - miscellaneous
(1)
Skin and connective tissue diseases
(3)
Pain - Inflammation
(2)
Infectious diseases
(1)
Plus ...
Virus diseases
(1)
Congenital, genetic and rare diseases
(1)
Diagnostic and therapeutic techniques
(6)
Plus ...
Drug therapy
(5)
Therapeutic patient education
(1)
Nutrition, dietetics
(1)
Alternative medicine
(1)
Rehabilitation techniques
(1)
Vaccine
(1)
Population groups
(3)
Plus ...
Paediatrics
(3)
Economics and public health
(2)
Plus ...
Health economics
(2)
Organisation of care
(1)
Occupational health
(1)
Content type
Drugs, devices and medical acts
(4)
Plus ...
Medicine
(4)
Practice Guidelines and Other Guides
(4)
Plus ...
Practice guidelines
(3)
Public Health guideline
(1)
Date
Last five years
(1)
This year
(1)
Manufacturer
inconnu
(1)
industriels
(1)
Language
Français
(8)
Active substance
abatacept
(1)
aciclovir
(1)
acide folinique
(1)
acide folique
(1)
adalimumab
(4)
alcool
(2)
alemtuzumab
(1)
amitriptyline
(1)
argent
(1)
aspirine
(1)
azathioprine
(2)
basiliximab
(1)
chloroquine
(1)
ciclosporine
(2)
colestyramine
(1)
cyclophosphamide
(1)
etanercept
(1)
famciclovir
(1)
gabapentine
(1)
galactose
(1)
graphite
(1)
hydrocortisone
(1)
infliximab
(8)
orlistat
(1)
potassium
(1)
prednisolone
(2)
prednisone
(3)
rituximab
(1)
rosuvastatine
(1)
sirolimus
(1)
stiripentol
(1)
sulfasalazine
(2)
valaciclovir
(1)
zinc
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 4 results
Shingles vaccination recommendations and the role of the Shingrix vaccine
Public Health guideline
- Posted on 7/3/2024
Download
abstract
Add to
my selection
Rheumatoid arthritis: Medical, social and organisational aspects of treatment (excluding surgery and drugs)
Practice guidelines
- Posted on 21/5/2007 - Mis à jour le 19/12/2008
Download
abstract
Add to
my selection
Rheumatoid arthritis - Diagnosis and initial management
Practice guidelines
- Posted on 27/5/2009
Add to
my selection
See 4 result in Practice Guidelines and Other Guides
Drugs, devices and medical acts
- 4 results
REMSIMA
Medicine
- Posted on 18/9/2024
Add to
my selection
FLIXABI (infliximab)
Medicine
- Posted on 7/11/2016 - Mis à jour le 12/6/2019
Add to
my selection
INFLECTRA (infliximab)
Medicine
- Posted on 5/8/2021
Add to
my selection
See 4 result in Drugs, devices and medical acts
Français
English
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
Ez99KD559GNMkA62